SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001683168-19-002753
Filing Date
2019-08-26
Accepted
2019-08-23 19:42:07
Documents
2
Period of Report
2018-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT gala_8ka.htm 8-K/A 19792
2 AMENDMENT NO. 3 EXECUTIVE AGREEMENT BETWEEN GALA PHARMACEUTICAL, INC. AND MAQSOO gala_8ka-ex1001.htm EX-10.1 78034
  Complete submission text file 0001683168-19-002753.txt   99264
Mailing Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612
Business Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612 949-851-9261
Gala Pharmaceutical Inc. (Filer) CIK: 0001513403 (see all company filings)

IRS No.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K/A | Act: 34 | File No.: 000-55998 | Film No.: 191050365
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl